Kent Thoelke, Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contract research provider discusses decentralized and virtual clinical trials, and how this technology helps in overcoming racial disparities in trials.
Dr. Richard Levitan, an airway specialist who has practiced emergency medicine for over 30 years, and co-founder and executive director of Prone2Help, a national 501c3 non-profit organization, discusses proning and how it has positively impacted patients with COVID-19, the need for proning cushions in the U.S., and how others can help support the cause.
Returning guest, Dr. Richard Shane, PhD, co-founder and Chief Clinical Officer of Sleep Easy (formerly Sleep Easily) discusses the new Sleep Easy Mobile App launched in Dec 2020 that is based on his proven methodology of Neurosomatic Patterning for Sleep™.
Veronica Villanueva, a certified health coach, Cordon Bleu trained chef, and author of the book “The Grace of Cancer: Lessons in Humility and Greatness” shares her personal journey battling cancer, (beating it once, though she has recently found it has returned) and discusses the role CBD products and medicinal cannabis can have in the healing journey and offers key information to know when researching CBD products and medicinal cannabis. She notes that trying experimental therapy while refusing established treatments is dangerous.
Laine Richards, 18, shares her personal journey living with active epilepsy and how she went to Capitol Hill to speak with members of congress about the importance of epilepsy research and funding. For the past four years, she has represented the state of Michigan with the Epilepsy Foundation of America’s”Teens Speak Up!” program. Laine was recently awarded a $10,000 scholarship through the UCB Family Epilepsy Scholarship Program that offers scholarships to people living with epilepsy, family members, and caregivers.
Dr. William Flood, Chief Medical Officer for Eviti at NantHealth, discusses new significant findings from Eviti Connect, presented at the San Antonio Breast Cancer Symposium 2020, around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer. These findings show the promise of biosimilars as the oncology community continues to use them more to provide high-quality cancer care while lowering overall costs.
Returning guest, Dr. Len Friedland, VP and Director, Scientific Affairs and Public Health, Vaccines at GSK discusses meningococcal disease, symptoms, and the 2 different types of vaccines available for MenACWY and MenB. He is joined by meningitis survivor and GSK spokesperson, Jamie Schanbaum who shares her experience with meningococcal septicemia and who founded the J.A.M.I.E. Group (Joint Advocacy of Meningococcal Information & Education) in 2009 to help raise awareness about the impact of meningitis and the importance of vaccination.
Rajni Dronamraju, Senior Director, Charitable Giving Strategy at Genentech, discusses Genentech’s ongoing efforts to address the impact of trauma, stress and racism on the health and well-being of low-income kids and families across the Bay Area. She also discusses the recent launch of the All In For Kids multi-donor fund to unite Bay Area nonprofits, advocates and leaders in advancing solutions that address childhood adversity and trauma. Genentech seeded the fund with $5M. Listeners can learn more at The Resilience Effect.
Antony Koblish, co-founder and CEO of TELA Bio, a medtech company focused on solving the issues related to hernia repair and soft tissue reconstruction, discusses OviTex®, a next generation mesh that features the safety and naturalness of biologic material and the strength and durability of synthetic mesh. TELA Bio worked with 100+ general and plastic surgeons to purposefully design a portfolio of soft-tissue repair solutions that provide a more natural hernia repair option.
Dr. Peter S. Tippett, founder and CEO of careMESH, a healthcare communication platform that enables hospitals and clinicians to securely share patient data with any other U.S. healthcare provider discusses how healthcare interoperability has changed over the years and how COVID accelerated the need for better patient-to-physician transfer of care.